Triple-negative breast cancer (TNBC), the most aggressive subtype of breast cancer, refers to a broad category of breast cancer that tests negative for estrogen receptors (ER), progesterone receptors (PRs), and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and breast cancer.